Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia-Reference-Cited by-同舟云学术

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Published:2019-01-11 Issue:10 Volume:219 Page:1536-1544
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Talbot George H¹^ORCID,Das Anita²,Cush Stephanie³,Dane Aaron⁴,Wible Michele⁵,Echols Roger⁶,Torres Antoni⁷,Cammarata Sue⁸^ORCID,Rex John H⁹,Powers John H¹⁰,Fleming Thomas¹¹,Loutit Jeffrey¹²,Hoffmann Steve³,

Affiliation:

1. Talbot Advisors LLC, Anna Maria, Florida

2. ADStat, Guerneville, California

3. Foundation for the National Institutes of Health, North Bethesda, Maryland

4. DaneStat, Macclesfield, Cheshire, United Kingdom

5. Pfizer Inc, Collegeville, Pennsylvania

6. Infectious Disease Drug Development Consulting, LLC, Easton, Connecticut

7. Servei de Pneumologia, Hospital Clinic, IDIBAPS, CIBERES, Universitat de Barcelona, Spain

8. Melinta Therapeutics, New Haven, Connecticut

9. F2G Ltd, Eccles, Manchester, United Kingdom

10. George Washington University School of Medicine, Washington, District of Columbia

11. University of Washington, Seattle

12. The Medicines Company, San Diego, California

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/219/10/1536/28798705/jiy578.pdf

Reference21 articles.

1. Progress in the fight against multidrug-resistant bacteria 2005-2016: modern noninferiority trial designs enable antibiotic development in advance of epidemic bacterial resistance;Rex;Clin Infect Dis,2017

2. Developing outcomes assessments as endpoints for registrational clinical trials of antibacterial drugs: 2015 update from the biomarkers consortium of the foundation for the National Institutes of Health;Talbot;Clin Infect Dis,2016

3. Good enough: a primer on the analysis and interpretation of noninferiority trials;Kaul;Ann Intern Med,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence;Future Microbiology;2024-01-22

2. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study;Critical Care;2024-01-03

3. Machine learning to identify risk factors associated with the development of ventilated hospital-acquired pneumonia and mortality: implications for antibiotic therapy selection;Frontiers in Medicine;2023-12-15

4. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment;Antimicrobial Agents and Chemotherapy;2023-12-14

5. Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments;Antibiotics;2023-11-12